144 related articles for article (PubMed ID: 16136168)
1. Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891.
Smith FO; Alonzo TA; Gerbing RB; Woods WG; Arceci RJ;
Leukemia; 2005 Dec; 19(12):2054-62. PubMed ID: 16136168
[TBL] [Abstract][Full Text] [Related]
2. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.
Ravindranath Y; Chang M; Steuber CP; Becton D; Dahl G; Civin C; Camitta B; Carroll A; Raimondi SC; Weinstein HJ;
Leukemia; 2005 Dec; 19(12):2101-16. PubMed ID: 16136167
[TBL] [Abstract][Full Text] [Related]
3. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials.
Gibson BE; Wheatley K; Hann IM; Stevens RF; Webb D; Hills RK; De Graaf SS; Harrison CJ
Leukemia; 2005 Dec; 19(12):2130-8. PubMed ID: 16304572
[TBL] [Abstract][Full Text] [Related]
4. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.
Ravindranath Y; Yeager AM; Chang MN; Steuber CP; Krischer J; Graham-Pole J; Carroll A; Inoue S; Camitta B; Weinstein HJ
N Engl J Med; 1996 May; 334(22):1428-34. PubMed ID: 8618581
[TBL] [Abstract][Full Text] [Related]
5. Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials.
Lie SO; Abrahamsson J; Clausen N; Forestier E; Hasle H; Hovi L; Jonmundsson G; Mellander L; Siimes MA; Yssing M; Zeller B; Gustafsson G; ;
Leukemia; 2005 Dec; 19(12):2090-100. PubMed ID: 16304571
[TBL] [Abstract][Full Text] [Related]
6. Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000.
Ribeiro RC; Razzouk BI; Pounds S; Hijiya N; Pui CH; Rubnitz JE
Leukemia; 2005 Dec; 19(12):2125-9. PubMed ID: 16281077
[TBL] [Abstract][Full Text] [Related]
7. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
[TBL] [Abstract][Full Text] [Related]
9. Outcomes in childhood AML in the absence of transplantation in first remission--Children's Cancer Group (CCG) studies 2891 and CCG 213.
Castellino SM; Alonzo TA; Buxton A; Gold S; Lange BJ; Woods WG
Pediatr Blood Cancer; 2008 Jan; 50(1):9-16. PubMed ID: 17252564
[TBL] [Abstract][Full Text] [Related]
10. Pilot study of idarubicin-based intensive-timing induction therapy for children with previously untreated acute myeloid leukemia: Children's Cancer Group Study 2941.
Lange BJ; Dinndorf P; Smith FO; Arndt C; Barnard D; Feig S; Feusner J; Seibel N; Weiman M; Aplenc R; Gerbing R; Alonzo TA
J Clin Oncol; 2004 Jan; 22(1):150-6. PubMed ID: 14701777
[TBL] [Abstract][Full Text] [Related]
11. Twenty years of Polish experience with three consecutive protocols for treatment of childhood acute myelogenous leukemia.
Dluzniewska A; Balwierz W; Armata J; Balcerska A; Chybicka A; Kowalczyk J; Matysiak M; Ochocka M; Radwanska U; Rokicka-Milewska R; Sonta-Jakimczyk D; Wachowiak J; Wysocki M
Leukemia; 2005 Dec; 19(12):2117-24. PubMed ID: 16107894
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission.
Cassileth PA; Harrington DP; Appelbaum FR; Lazarus HM; Rowe JM; Paietta E; Willman C; Hurd DD; Bennett JM; Blume KG; Head DR; Wiernik PH
N Engl J Med; 1998 Dec; 339(23):1649-56. PubMed ID: 9834301
[TBL] [Abstract][Full Text] [Related]
13. Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology Group.
Cassileth PA; Andersen JW; Bennett JM; Harrington DP; Hines JD; Lazarus HM; Mazza JJ; McGlave PP; O'Connell MJ; Paietta E
Leukemia; 1992; 6 Suppl 2():116-9. PubMed ID: 1578910
[TBL] [Abstract][Full Text] [Related]
14. Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report.
Entz-Werle N; Suciu S; van der Werff ten Bosch J; Vilmer E; Bertrand Y; Benoit Y; Margueritte G; Plouvier E; Boutard P; Vandecruys E; Ferster A; Lutz P; Uyttebroeck A; Hoyoux C; Thyss A; Rialland X; Norton L; Pages MP; Philippe N; Otten J; Behar C;
Leukemia; 2005 Dec; 19(12):2072-81. PubMed ID: 16136166
[TBL] [Abstract][Full Text] [Related]
15. Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.
Gamis AS; Woods WG; Alonzo TA; Buxton A; Lange B; Barnard DR; Gold S; Smith FO;
J Clin Oncol; 2003 Sep; 21(18):3415-22. PubMed ID: 12885836
[TBL] [Abstract][Full Text] [Related]
16. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group.
Woods WG; Kobrinsky N; Buckley JD; Lee JW; Sanders J; Neudorf S; Gold S; Barnard DR; DeSwarte J; Dusenbery K; Kalousek D; Arthur DC; Lange BJ
Blood; 1996 Jun; 87(12):4979-89. PubMed ID: 8652810
[TBL] [Abstract][Full Text] [Related]
17. Treatment strategy and long-term results in pediatric patients treated in two consecutive AML-GATLA trials.
Armendariz H; Barbieri MA; Freigeiro D; Lastiri F; Felice MS; Dibar E
Leukemia; 2005 Dec; 19(12):2139-42. PubMed ID: 16304573
[No Abstract] [Full Text] [Related]
18. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission.
Woods WG; Neudorf S; Gold S; Sanders J; Buckley JD; Barnard DR; Dusenbery K; DeSwarte J; Arthur DC; Lange BJ; Kobrinsky NL;
Blood; 2001 Jan; 97(1):56-62. PubMed ID: 11133742
[TBL] [Abstract][Full Text] [Related]
19. Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial.
Schlenk RF; Benner A; Hartmann F; del Valle F; Weber C; Pralle H; Fischer JT; Gunzer U; Pezzutto A; Weber W; Grimminger W; Preiss J; Hensel M; Fröhling S; Döhner K; Haas R; Döhner H;
Leukemia; 2003 Aug; 17(8):1521-8. PubMed ID: 12886238
[TBL] [Abstract][Full Text] [Related]
20. Autologous bone marrow transplantation for children with AML in first remission.
Neudorf S; Sanders J; Kobrinsky N; Alonzo TA; Buxton A; Buckley JD; Howells W; Gold S; Barnard DR; DeSwarte J; Kalousek D; Lange BJ; Woods WG
Bone Marrow Transplant; 2007 Aug; 40(4):313-8. PubMed ID: 17563741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]